Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2023-08-01
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols
NCT01728597
Cardiac Effects From Radiation Therapy by MRI
NCT04486573
Clinical Validation of an Artificial Intelligence Tool to Predict Inversion Time
NCT06855238
CMR Imaging of Autoimmune Diseases
NCT04673409
The Effect of Short-term Bed Rest on Cardiac Function Measured by Cardiac Magnetic Resonance Imaging
NCT06644872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Included patients will undergo clinical cMRI following international and national standards: only the acquisition strategy will vary. The investigators will successively recruit patients presenting for routine cardiac MRI. The acquisition strategy of the MRI - either automated or manual - will alternate to avoid comparison bias.
The MRI protocol will be the same for both arms and consists of standardized sequences acquired before and after contrast administration. Recruitment will be performed at a single location, in the radiology department. Patients will be recruited on a daily, consecutive basis during clinical practice.
No questionnaire will be used for this study. No biological material will be sampled. Observational data about the acquisition process, potential errors, and patient characteristics will be recorded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Automatic acquisition
Clinical MRI planning performed automatically by an AI-based software
Automation of cardiac MRI acquisition
The intervention will consist of the automation of the cMRI examination.
Manual Acquisition
Clinical MRI planning performed manually by a specialized radiology technician
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Automation of cardiac MRI acquisition
The intervention will consist of the automation of the cMRI examination.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Research consent form obtained after information procedure.
* Complete cardiac MRI protocol performed.
Exclusion Criteria
* Implantable cardiac device
* Incomplete cardiac examination due to early termination by the patient.
* Incomplete data on examination parameters (missing forms).
* Incompatible MRI protocol
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carl Glessgen
Medical Doctor, Consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carl Glessgen, MD
Role: PRINCIPAL_INVESTIGATOR
Radiologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital, Geneva
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-01047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.